Why rigid classical production lines have had their day: The new era of pharmaceutical secondary packaging
The pharmaceutical industry is facing a paradigm shift: increasing demand volatility and the trend towards personalised and specialised therapies are requiring flexible production structures, while highly standardised, inflexible production structures are increasingly losing their competitive edge.
Complex Pharmaceuticals has deliberately pursued a different strategic approach at the Vienna site: a consistently modular production structure with maximum adaptability.
What does this mean in practice?
In our new facility, we have rethought secondary packaging from a technological perspective. Instead of a monolithic ‘single-purpose plant’, we use modular systems. This enables us:
- Short changeover times enable us to implement format changes in considerably less time than in traditional production structures. This operational efficiency translates directly into economic advantages for our clients.
- Our production structure enables consistently high process reliability and efficiency across all batch sizes — from small series for specialised products through to high-volume market production. Optimised changeover processes ensure permanently economical cost structures.
Conclusion
Modularity is, for us, the answer to the cost pressure at the European location. Through modern and flexibly designed production technologies, we contribute to strengthening the competitiveness of Austria as a pharmaceutical location and to supporting a demand-oriented supply of pharmaceutical products.
FAQ
1. Why is modularity in secondary packaging so important today?
The increasing differentiation of therapeutic approaches is accompanied by growing demand for individual solutions and variable batch sizes. Our modular systems allow us to respond flexibly to these requirements without sacrificing economic viability.
2. How do clients benefit concretely from rapid format changes?
Time is money, especially at market entry. Our short changeover times drastically reduce lead times. Our partners gain agility and can respond more quickly to demand fluctuations in the market.
3. Can modular lines also process large-scale series efficiently?
Absolutely. Modularity does not mean ‘small’, but ‘adaptable’. We use the high degree of automation of our lines to handle large-volume orders with the same precision and speed as specialised small batches.